| 46.04 Data as of May 24 |  -0.31 / -0.67%Today’s Change | 25.90 Today|||52-Week Range 48.47 | +12.54% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Leighton Frank Thomson Chief Scientific Officer |  Buy | 6/05/2012 | 147,240 | $27.45 | $4.0M | +67.78% |
Sagan Paul L President & Chief Executive Officer |  Sale | 12/12/2012 | 57,319 | $40.24 | $2.3M | +15.19% |
Canner Debra L Senior Vice President-Human Resources | Sale | 7/27/2012 | 56,309 | $35.32 | $2.0M | +28.39% |
Leighton Frank Thomson Chief Executive Officer | Buy | 2/08/2013 | 50,000 | $35.31 | $1.8M | +29.98% |
Hughes Robert W Executive VP-Global Sales, Marketing & Services | Sale | 7/30/2012 | 46,195 | $35.72 | $1.7M | +28.53% |
Sagan Paul L Director | Sale | 5/22/2013 | 30,000 | $46.99 | $1.4M | -0.17% |
Haratunian Melanie General Counsel & Executive Vice President | Sale | 3/15/2013 | 38,393 | $34.89 | $1.3M | +32.72% |
Canner Debra L Senior Vice President-Human Resources | Buy | 7/27/2012 | 35,000 | $32.71 | $1.1M | +28.39% |
Leighton Frank Thomson Chief Executive Officer | Buy | 3/13/2013 | 30,000 | $34.75 | $1.0M | +32.83% |
Conrades George H Director | Buy | 2/12/2013 | 27,325 | $36.74 | $1.0M | +25.31% |
.
